Adalimumab-Bwwd

HADLIMA

Tumor Necrosis Factor Blocker

NADAC/unit $611.3513

No Shortage Tier 1: 51.7% PA Req: 275.4%

Adalimumab-Bwwd suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.

vs. brand HADLIMA: Generic saves up to -6014% per unit

Covered Lives

Market Intelligence

2025-11-05 Class II Recall: Samsung Bioepis Co., Ltd.

Explore in the Ecosystem

rxsaver.aiCompare prices for Adalimumab-Bwwd drfinder.aiFind doctors who prescribe Adalimumab-Bwwd rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Adalimumab-Bwwd

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.